Parkinsonism & Related Disorders
Volume 16, Issue 3 , Pages 186-190 , March 2010

Cancer risk in association with Parkinson disease: A population-based study

  • Claudia Becker

      Affiliations

    • Basel Pharmacoepidemiology Unit, Hospital Pharmacy, University Hospital, Spitalstrasse 26, CH-4031 Basel, Switzerland
    • ,
  • Gunnar P. Brobert

      Affiliations

    • AstraZeneca Research & Development, 15185 Södertälje, Sweden
    • ,
  • Saga Johansson

      Affiliations

    • AstraZeneca Research & Development, 43183 Mölndal, Sweden
    • Institute of Medicine, Sahlgrenska Academy, Göteborg University, Sweden
    • ,
  • Susan S. Jick

      Affiliations

    • Boston Collaborative Drug Surveillance Program, Boston University Medical Center, 11 Muzzey Street, Lexington, MA 02421, USA
    • ,
  • Christoph R. Meier

      Affiliations

    • Basel Pharmacoepidemiology Unit, Hospital Pharmacy, University Hospital, Spitalstrasse 26, CH-4031 Basel, Switzerland
    • Boston Collaborative Drug Surveillance Program, Boston University Medical Center, 11 Muzzey Street, Lexington, MA 02421, USA
    • Corresponding Author InformationCorresponding author at: Basel Pharmacoepidemiology Unit, Hospital Pharmacy, University Hospital, Spitalstrasse 26, CH-4031 Basel, Switzerland. Tel.: +41 61 556 53 69; fax: +41 61 265 88 75.

Received 23 June 2009 ,Revised 23 September 2009 ,Accepted 6 November 2009.

References 

  1. Olsen JH, Friis S, Frederiksen K, McLaughlin JK, Mellemkjaer L, Moller H. Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer. 2005;92:201–205
  2. Moller H, Mellemkjaer L, McLaughlin JK, Olsen JH. Occurrence of different cancers in patients with Parkinson's disease. BMJ. 1995;310:1500–1501
  3. Minami Y, Yamamoto R, Nishikouri M, Fukao A, Hisamichi S. Mortality and cancer incidence in patients with Parkinson's disease. J Neurol. 2000;247:429–434
  4. Jansson B, Jankovic J. Low cancer rates among patients with Parkinson's disease. Ann Neurol. 1985;17:505–509
  5. Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T. A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev. 2007;16:1260–1265
  6. Elbaz A, Peterson BJ, Bower JH, Yang P, Maraganore DM, McDonnell SK, et al. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study. Mov Disord. 2005;20:719–725
  7. Greenamyre JT, Hastings TG. Biomedicine. Parkinson's – divergent causes, convergent mechanisms. Science. 2004;304:1120–1122
  8. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004;44:239–267
  9. Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, et al. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27. Proc Natl Acad Sci U S A. 2003;100:5956–5961
  10. Kim RH, Mak TW. Tumours and tremors: how PTEN regulation underlies both. Br J Cancer. 2006;94:620–624
  11. Allam MF, Campbell MJ, Hofman A, Del Castillo AS, Fernandez-Crehuet Navajas R. Smoking and Parkinson's disease: systematic review of prospective studies. Mov Disord. 2004;19:614–621
  12. Fiala KH, Whetteckey J, Manyam BV. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?. Parkinsonism Relat Disord. 2003;9:321–327
  13. Zanetti R, Loria D, Rosso S. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature. Melanoma Res. 2006;16:201–206
  14. Wood L, Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf. 2004;27:871–881
  15. Jick H. A database worth saving. Lancet. 1997;350:1045–1046
  16. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, et al. Validity of the general practice research database. Pharmacotherapy. 2003;23:686–689
  17. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med. 2007;356:29–38
  18. Hernan MA, Logroscino G, Rodriguez LA. A prospective study of alcoholism and the risk of Parkinson's disease. J Neurol. 2004;251(Suppl. 7):vII14–vII17
  19. Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR. Calcium-channel blockers and risk of cancer. Lancet. 1997;349:525–528
  20. Meier CR, Derby LE, Jick SS, Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med. 2000;160:349–353
  21. Kaye JA, Meier CR, Walker AM, Jick H. Statin use, hyperlipidaemia, and the risk of breast cancer. Br J Cancer. 2002;86:1436–1439
  22. Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002;252:206–224
  23. Elbaz A, Peterson BJ, Yang P, Van Gerpen JA, Bower JH, Maraganore DM, et al. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology. 2002;13:157–164
  24. Lerner MR, Goldman RS. Skin colour, MPTP, and Parkinson's disease. Lancet. 1987;2:212
  25. Olsen JH, Friis S, Frederiksen K. Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology. 2006;17:582–587
  26. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. Parkinsonism Relat Disord. 2006;12:185–189
  27. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease. Cancer Causes Control. 2007;18:705–711
  28. Vermeij JD, Winogrodzka A, Trip J, Weber WEJ. Parkinson's disease, levodopa-use and the risk of melanoma. Parkinsonism Relat Disord. 2009;15:551–553
  29. Hernan MA, Logroscino G, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology. 2006;66:1097–1099

☆ The review of this paper was entirely handled by an Associate Editor, Professor En-King Tan.

PII: S1353-8020(09)00277-6

doi: 10.1016/j.parkreldis.2009.11.005

Parkinsonism & Related Disorders
Volume 16, Issue 3 , Pages 186-190 , March 2010

Article Tools